ISM6331

· InSilico Medicine Hong Kong Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISM6331, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors [Phase 1]